As India's Q4 earnings cycle shows signs of bottoming out, Marcellus Investment Managers lays out a precise three-theme playbook, and warns that macro headwinds from crude oil could undercut the recovery.India's Q4 earnings season has delivered a pleasant surprise. Nifty 100 profits grew 13% year-on-year, with the bulk of that strength concentrated in the final quarter. But for Pramod Gubbi, Co-Founder of Marcellus Investment Managers, the more important question is not what just happened, but whether it can last."We are reversing the situation from the last couple of years," Gubbi explained. Micro and macro have "completely reversed"Last couple of years the macro looked quite sanguine whereas we were struggling to see earnings growth just when valuations were pretty high. That earnings cycle seems to be bottoming out based on what we have seen in Q4, clearly there are more upgrades than downgrades," says Gubbi.The complication, however, is that just as the corporate earnings picture is improving, macro forces, crude oil prices, rupee depreciation, rising bond yields, inflation, are moving in the wrong direction. The micro and macro have, in his words, "completely reversed."Q4 Earnings SnapshotNifty 100 profit growth (YoY)+13%Earnings trendMore upgrades than downgradesKey riskCrude-driven raw material costsValuation verdictNo compelling broad-market opportunityPaints: Crude proves to be a cloudIn paints, competition is stabilising, but crude remains a cloud. Asian Paints' quarterly results, with topline up nearly 10% and improving margins, illustrate a broader trend across building materials. The sector went through an unusually rough patch as aggressive new entrants disrupted a previously stable competitive landscape. Gubbi sees that intensity easing. Market shares appear to be settling, volume growth is recovering, and Asian Paints' own push into vertical integration, manufacturing more of its raw materials in-house, should widen its cost and pricing advantage over rivals once those investments come on stream. The near-term risk remains crude-linked input costs, but the structural story is intact."Just when we thought the earnings cycle is bottoming out, we are faced with macro headwinds — which puts a question mark on the sustainability of the recovery, says Gubbi.Pharma & chemicals alignedPharma and chemicals are structurally and cyclically aligned. Gubbi flags both sectors as standing out for a rare combination of improving fundamentals and reasonable valuations. US pricing pressure — which weighed heavily on Indian pharma exporters for several years — is now largely behind the sector. In chemicals, the excess supply overhang from China is also fading. Domestic healthcare, spanning hospitals, diagnostics, and pharmaceuticals, remains one of the firmest structural growth stories in the market.Three themes for a difficult marketAsked directly where to put money, Gubbi's answer is specific and deliberately narrow.Private sector financialsValuations are at their most compelling in decades. A rare pocket of clear value in an otherwise expensive market.HealthcareStructural growth across pharma, hospitals, and diagnostics — with valuations that are not stretched.Manufactured exportsRupee depreciation is boosting competitiveness; global re-industrialisation is driving demand for transformers, turbines, and electrical supply chain.AI-driven power demand a tailwind for Indian capital goods companies On the manufactured exports theme, Gubbi makes an astute macro-to-micro link. The Western world's push to re-industrialise, particularly across electricity infrastructure to power AI data centres, is generating strong global demand for the kind of capital goods that quality Indian manufacturers produce. Rupee weakness adds a further competitive edge. The AI-driven power demand story, he argues, is not just hype; it is a durable tailwind for Indian capital goods companies with exposure to global supply chains.For investors navigating a market that offers neither cheap valuations nor a clean macro backdrop, Gubbi's message is clear: be selective, stay bottom-up, and concentrate where growth and value coincide.